序贯器官衰竭评估评分及其动态变化对血液重症监护病房死亡率的预测价值
该回顾性研究纳入2024年5月至6月中国医学科学院血液病医院重症医学诊疗中心收治的79例血液病危重症患者,计算HCU入住前2天至后2天的SOFA评分及ΔSOFA。79例患者HCU死亡率为54.4%,死亡组全体、白血病及HSCT患者的D1、D2、D3评分和ΔD1均较非死亡组明显增高(P值均<0.05)。ROC分析显示D1、D2、D3评分和ΔD1均可预测死亡率(P<0.001)。
要点
- 79例血液病危重症患者HCU死亡率为54.4%。
- 全体患者D1、D2、D3评分和ΔD1均可预测HCU死亡率(P<0.001),AUC分别为0.786、0.866、0.901、0.843。
- 全体患者中D3评分特异度最高(100%),ΔD1灵敏度最高(86.84%)。
核心结论
- 对于住院于HCU的血液危重症、白血病和HSCT患者,D1、D2、D3评分和ΔD1与HCU死亡率明显相关。
研究设计与样本
- 回顾性临床研究,纳入2024年5月至6月中国医学科学院血液病医院重症医学诊疗中心收治的79例血液病危重症患者。
- 计算患者自住院于HCU前2天至后2天的SOFA评分及ΔSOFA,应用ROC曲线研究其死亡率预测价值。
主要发现
- 79例患者HCU死亡率为54.4%。
- 死亡组全体患者、白血病患者和HSCT患者住院第1~3天SOFA(D1、D2、D3)评分和第1天ΔSOFA(ΔD1)均较非死亡组明显增高(P值均<0.05)。
- 全体患者D1、D2、D3评分和ΔD1均可预测死亡率(P<0.001),AUC分别为0.786、0.866、0.901、0.843,灵敏度分别为74.36%、57.89%、62.85%、86.84%,特异度分别为70.00%、100%、100%、67.65%。
- HSCT组中D-1、D1、D2、D3评分和ΔD1均可预测HCU死亡率,AUC分别为0.833、0.794、0.871、0.846、0.795;灵敏度分别为100%、85.71%、71.43%、57.14%、57.14%;特异度分别为73.33%、70.59%、91.33%、100%、100%。
- 白血病组中D1、D2、D3评分和ΔD1可预测HCU死亡率,AUC分别为0.760、0.829、0.846、0.756;灵敏度分别为71.43%、78.57%、53.85%、71.43%;特异度分别为76.19%、78.95%、100%、63.16%。
关键数值与推荐
- 全体患者中D3评分特异度最高(100%),ΔD1灵敏度最高(86.84%)。
- HSCT组和白血病组患者中,D1和D3评分的灵敏度及特异度均高于ΔD1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the value of Sequential Organ Failure (SOFA) score and its dynamics (ΔSOFA) in predicting mortality in hematology care unit (HCU) . Methods: A retrospective clinical study was conducted on 79 critically ill hematologic patients admitted to the Center for Critical Care Medicine, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, between May and June 2024. SOFA scores and ΔSOFA were calculated within 2 days before and after HCU admission. The predictive value of SOFA and ΔSOFA in mortality was assessed using receiver operating characteristic (ROC) curve analysis. Results: Among the 79 patients, the HCU mortality rate was 54.4%. The SOFA scores on days 1-3 (D1, D2, and D3) and ΔSOFA on day 1 (ΔD_1) of all patients, leukemia patients and hematopoietic stem cell transplantation (HSCT) patients were significantly higher in the death group compared with the non-death group (all P<0.05). ROC curve analysis revealed that the D_1, D_2, D_3 scores, and ΔD_1 significantly predicted mortality (P<0.001), with areas under the curve (AUCs) of 0.786, 0.866, 0.901, and 0.843, respectively. The sensitivity values were 74.36%, 57.89%, 62.85%, and 86.84%, while specificity values were 70%, 100%, 100%, and 67.65%, respectively. In the HSCT group, the D_-1, D_1, D_2, D_ 3, scores and ΔD_1 were predictive of HCU mortality, with AUCs of 0.833, 0.794, 0.871, 0.846, and 0.795, respectively. Sensitivity values for these scores were 100%, 85.71%, 71.43%, 57.14%, and 57.14%, while specificity values were 73.33%, 70.59%, 91.33%, 100%, and 100%, respectively. In the leukemia group, the D_1, D_2, D_3 scores, and ΔD_1 were predictive of HCU mortality, with AUCs of 0.760, 0.829, 0.846, and 0.756, respectively. Sensitivity values were 71.43%, 78.57%, 53.85%, and 71.43%, while specificity values were 76.19%, 78.95%, 100%, and 63.16%, respectively. For all patients, the D_3 score exhibited the highest specificity, while the ΔD_1 demonstrated the highest sensitivity. For patients in both the HSCT and leukemia groups, the sensitivity and specificity values of the D_1 and D_3 scores exceeded those of the ΔD_1. Conclusion: For patients with hematologic critical illness, including leukemia and those undergoing HSCT hospitalized in the HCU, D_1, D_2, D_ 3 scores and ΔD_1 are significantly associated with HCU mortality. 目的: 探讨序贯器官衰竭评估(SOFA)评分及其动态变化(ΔSOFA)在血液重症监护病房(HCU)中预测死亡率的价值。 方法: 回顾性收集2024年5月至2024年6月中国医学科学院血液病医院重症医学诊疗中心收治的79例血液病危重症患者的临床数据,计算患者自住院于HCU前2 d至后2 d的SOFA评分及ΔSOFA。应用受试者工作特征曲线(ROC)研究SOFA评分及ΔSOFA在死亡率预测中的价值。 结果: 79例患者的HCU死亡率为54.4%。死亡组全体患者、白血病患者和造血干细胞移植(HSCT)患者住院第1~3天SOFA(D_1、D_2、D_3)评分和第1天ΔSOFA(ΔD_1)均较非死亡组明显增高(P值均<0.05)。ROC曲线分析显示,D_1、D_2、D_3评分和ΔD_1均可预测患者死亡率(P<0.001),曲线下面积(AUC)分别为0.786、0.866、0.901、0.843,灵敏度分别为74.36%、57.89%、62.85%、86.84%,特异度分别为70.00%、100%、100%、67.65%。HSCT组中,D_-1、D_1、D_2、D_3评分和ΔD_1均可预测HCU死亡率,AUC分别为0.833、0.794、0.871、0.846、0.795;灵敏度分别为100%、85.71%、71.43%、57.14%、57.14%;特异度分别为73.33%、70.59%、91.33%、100%、100%。白血病组中,D_1、D_2、D_3评分和ΔD_1可预测HCU死亡率,AUC分别为0.760、0.829、0.846、0.756;灵敏度分别为71.43%、78.57%、53.85%、71.43%;特异度分别为76.19%、78.95%、100%、63.16%。对于全体患者,D_3评分特异度最高,ΔD_1灵敏度最高。对于HSCT组和白血病组患者,D_1和D_3评分的灵敏度及特异度均高于ΔD_1。 结论: 对于住院于HCU的血液危重症、白血病和HSCT患者,D_1、D_2、D_3评分和ΔD_1与HCU死亡率明显相关。.
引用
- Wang JJ, Zhang J, Zhang B, et al. [The value of sequential organ failure assessment and its dynamic changes in predicting mortality in hematology intensive care unit]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40059679. doi:10.3760/cma.j.cn121090-20241130-00510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。